(Q51948433)

18 April 2018

title

Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population. (English)

1 reference

18 April 2018

1 reference

Toshiyuki Someya

1

1 reference

18 April 2018

Kazutaka Shimoda

2

1 reference

18 April 2018

Yutaro Suzuki

3

1 reference

18 April 2018

Satoshi Sato

4

1 reference

18 April 2018

Yoshiaki Kawashima

5

1 reference

18 April 2018

Genta Hirokane

6

1 reference

18 April 2018

Sachiyo Morita

7

1 reference

18 April 2018

Aya Yokono

8

1 reference

18 April 2018

Saburo Takahashi

9

1 reference

18 April 2018

language of work or name

English

0 references

publication date

4 June 2003

1 reference

18 April 2018

published in

Neuropsychopharmacology

1 reference

18 April 2018

volume

28

1 reference

18 April 2018

issue

8

1 reference

18 April 2018

page(s)

1501-1505

1 reference

18 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300213

exact match

0 references

cites work

Substantial rise in sparteine metabolic ratio during haloperidol treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

On the metabolism of haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Use of antisera in the isolation of human specific conjugates of haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300213

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300213

1 reference

18 April 2018

PubMed ID

12784098

1 reference

18 April 2018